Travaux scientifiques

Prof. Dr. Ahmet Taner Sümbül

127 publications. La source de l’information est indiquée à côté de chaque publication.

Retour au profil

  1. Nutritional Indexes and Their Variations as Predictors of Atezolizumab Plus Chemotherapy Efficacy in Extensive-Stage Small Cell Lung Cancer: A Turkish Oncology Group Study

    Journal of Immunotherapy, 2026

    DOI 10.1097/cji.0000000000000610 PMID 42267536 Source : OpenAlex

  2. Adding immunotherapy to chemotherapy may improve survival after SCLC transformation in EGFR-mutant NSCLC: a multicenter real-world study

    Lung Cancer, 2026

    DOI 10.1016/j.lungcan.2026.109590 PMID 42664544 Texte intégral en libre accèsSource : ORCID

  3. Participant-Reported Preference for Pembrolizumab Administered Subcutaneously or Intravenously: A Randomized, Open-Label, Phase II Study

    JCO Oncology Practice, 2026

    DOI 10.1200/op-25-01248 PMID 42234938 Texte intégral en libre accèsSource : OpenAlex

  4. Real-life efficacy and safety data of lorlatinib treatment in ROS-1–positive advanced non-small cell lung cancer: Turkish Oncology Group (TOG) study.

    Journal of Clinical Oncology, 2025

    DOI 10.1200/jco.2025.43.16_suppl.e20659 Source : OpenAlex

  5. Real-World Outcomes in BRAF-Mutant Non-small Cell Lung Cancer: A Multicenter Analysis From the Turkish Oncology Group

    Clinical Lung Cancer, 2025

    DOI 10.1016/j.cllc.2025.07.015 PMID 40813186 2 citations (Europe PMC) Source : OpenAlex

  6. The frequency of driver mutations in non-small cell lung cancer patients: The Turkish nation-wide, observational, Registurk-Lung study (updated analysis).

    Journal of Clinical Oncology, 2025

    DOI 10.1200/jco.2025.43.16_suppl.e20501 Texte intégral en libre accèsSource : OpenAlex

  7. Efficacy of Immunotherapy Versus Chemotherapy in Advanced Pleural Mesothelioma: A Turkish Oncology Group (TOG) Study

    Medicina, 2025

    DOI 10.3390/medicina61040638 PMID 40282929 5 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  8. Real-world data on the efficacy and safety of trastuzumab emtansine in patients with metastatic breast cancer previously treated with pertuzumab: Turkish oncology group multicenter study

    Journal of Chemotherapy, 2024

    DOI 10.1080/1120009x.2024.2366683 PMID 38904164 1 citation (Europe PMC) Source : OpenAlex

  9. Treatment outcomes and prognostic factors in patients with driver mutant non-small cell lung cancer and de novo brain metastases

    Scientific Reports, 2024

    DOI 10.1038/s41598-024-56046-w PMID 38461209 16 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  10. 46P The frequency of driver mutations in non-small cell cancer patients: Analysis of the 5064 patients in the Turkish nation-wide, observational, registurkLung study

    ESMO Open, 2024

    DOI 10.1016/j.esmoop.2024.102625 Texte intégral en libre accèsSource : OpenAlex

  11. Are the results of clinical trials in patients with NSCLC reflected in real life? The Registurk-Lung study.

    Journal of Clinical Oncology, 2024

    DOI 10.1200/jco.2024.42.16_suppl.e20512 Texte intégral en libre accèsSource : OpenAlex

  12. Are the results of clinical trials in patients with NSCLC reflected in real life? The Registurk-Lung study

    Bursa Uludag University - AVESIS, 2024

    Source : OpenAlex

  13. Major and minor salivary gland cancers: A multicenter retrospective study

    Head & Neck, 2023

    DOI 10.1002/hed.27376 PMID 37084179 8 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  14. Impact of adding pertuzumab to trastuzumab plus chemotherapy in neoadjuvant treatment of HER2 positive breast cancer patients: a multicenter real-life HER2PATH study

    Acta Oncologica, 2023

    DOI 10.1080/0284186x.2023.2202330 PMID 37083566 3 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  15. Pertuzumab-mediated Cardiotoxicity: A Single Center Study.

    Sakarya Medical Journal, 2023

    DOI 10.31832/smj.1163527 1 citation (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  16. Thoracic Radiotherapy Effect on the Outcome in Extensive Stage Small Cell Lung Cancer

    Journal of College of Physicians And Surgeons Pakistan, 2023

    DOI 10.29271/jcpsp.2023.02.188 PMID 36797629 Texte intégral en libre accèsSource : OpenAlex

  17. Response to first-line chemotherapy regimen is associated with efficacy of ımmune checkpoint blockade therapies in patients with metastatic urothelial carcinoma

    International Journal of Clinical Oncology, 2022

    DOI 10.1007/s10147-021-02072-x PMID 34762201 5 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

  18. Sarkomlar ve Cilt Tümörleri

    Akademisyen Kitabevi eBooks, 2022

    DOI 10.37609/akya.1097 Texte intégral en libre accèsSource : OpenAlex

  19. Gastrointestinal Sistem Tümörleri-2

    Akademisyen Kitabevi eBooks, 2022

    DOI 10.37609/akya.1212 Texte intégral en libre accèsSource : OpenAlex

  20. By 2022, Cancer is Now a More Chronic Disease with Chronic Difficulties to Go Along with It

    Journal of Oncological Sciences, 2022

    DOI 10.37047/jos.2022-90068 2 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  21. Baş Boyun ve Santral Sinir Sistemleri Tümörleri

    Akademisyen Kitabevi eBooks, 2022

    DOI 10.37609/akya.1075 Texte intégral en libre accèsSource : OpenAlex

  22. Prognostic factors in patients with metastatic urothelial carcinoma who have treated with Atezolizumab

    International Journal of Clinical Oncology, 2021

    DOI 10.1007/s10147-021-01936-6 PMID 34023933 14 citations (Europe PMC) Source : ORCID

  23. Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma.

    Journal of Clinical Oncology, 2021

    DOI 10.1200/jco.2021.39.6_suppl.409 1 citation (OpenAlex) Source : OpenAlex

  24. Cardiotoxicity of trastuzumab emtansine (T-DM1): a single-center experience

    Journal of International Medical Research, 2021

    DOI 10.1177/03000605211053755 PMID 34898302 14 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  25. Upfront thoracic radiotherapy to primary lesion improves outcomes in patients with stage IV non-small cell lung cancer harboring EGFR mutations.

    PubMed, 2021

    PMID 34565003 4 citations (OpenAlex) Source : OpenAlex

  26. Turkish Society of Medical Oncology COVID-19 Pandemic Advisory Board Updated Recommendations for Medical Oncologists: Included Vaccination

    Journal of Oncological Sciences, 2021

    DOI 10.37047/jos.2021-81962 3 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  27. Upfront thoracic radiotherapy to primary lession improve outcomes in patients with stage IV non-small cell lung cancer harboring EGFR mutations.

    Journal of Clinical Oncology, 2021

    DOI 10.1200/jco.2021.39.15_suppl.e21167 1 citation (OpenAlex) Source : OpenAlex

  28. Paraneoplastik Sendromların Nadir Örnekleri

    Turkiye Klinikleri Medical Oncology - Special Topics, 2021

    Source : OpenAlex

  29. Impact of Baseline Neutrophil-to-Lymphocyte Ratio on Outcomes of GlioblastomaMultiforme Patients Treated with Standart Concurrent Chemoradiotherapy

    Acta Oncologica Turcica, 2021

    DOI 10.5505/aot.2021.81598 Texte intégral en libre accèsSource : OpenAlex

  30. Atezolizumab in Patients with Metastatic Urothelial Carcinoma Who Have Progressed After First-line Chemotherapy: Results of Real-life Experiences

    European Urology Focus, 2020

    DOI 10.1016/j.euf.2020.09.010 PMID 33008789 8 citations (Europe PMC) Source : ORCID

  31. Concurrent versus sandwich treatment in adjuvant treatment in high risk operated gastric cancer: A single center experience

    Journal of B.U.ON., 2020

    PMID 33277854 Source : ORCID

  32. Determination of the quality characteristics of naturally growing hawthorn in SuŞehri

    Acta Scientiarum Polonorum, Hortorum Cultus, 2020

    DOI 10.24326/asphc.2020.1.6 9 citations (OpenAlex) Texte intégral en libre accèsSource : ORCID

  33. Identification of genetic diversity among Juglans regia L. genotypes using molecular, morphological, and fatty acid data

    Genetic Resources and Crop Evolution, 2020

    DOI 10.1007/s10722-020-01072-6 8 citations (Europe PMC) Source : ORCID

  34. Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experience.

    Journal of Clinical Oncology, 2020

    DOI 10.1200/jco.2020.38.6_suppl.451 3 citations (OpenAlex) Source : OpenAlex

  35. 781P Prognostic factors in patients with metastatic urothelial carcinoma who have been treated with atezolizumab

    Annals of Oncology, 2020

    DOI 10.1016/j.annonc.2020.08.853 Texte intégral en libre accèsSource : OpenAlex

  36. Turkish Medical Oncology Society COVID-19 Pandemic Advisory Board Recommendations for Cancer Patients and Medical Oncologist

    Journal of Oncological Sciences, 2020

    DOI 10.37047/jos.2020-75364 4 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  37. Adjuvant chemotherapy in gastric cancer

    Journal of Cancer Prevention & Current Research, 2020

    DOI 10.15406/jcpcr.2020.11.00431 1 citation (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  38. Relationship Between Xanthine Oxidoreductase Activity and BRCA1 Levels in Patients with Stage IIIA and IIIB Non-Small Cell Lung Cancer Being Treated with Neoadjuvant Chemotherapy

    Journal of Oncological Sciences, 2020

    DOI 10.37047/jos.2019-71890 Texte intégral en libre accèsSource : OpenAlex

  39. Effectiveness of bendamustine in relapsed or refractory lymphoma cases: a Turkish Oncology Group study

    Archives of Medical Science, 2019

    DOI 10.5114/aoms.2019.83000 PMID 34336021 2 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  40. The hematologic parameters in metastatic castration-resistant prostate cancer patients treated with abiraterone acetate.

    Future oncology (London, England), 2019

    DOI 10.2217/fon-2018-0635 PMID 30977383 9 citations (Europe PMC) Source : ORCID

  41. Outcome of loco-regional radiotherapy in metastatic castration-resistant prostate cancer patients treated with abiraterone acetate.

    Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2019

    DOI 10.1007/s00066-019-01429-6 PMID 30701292 8 citations (Europe PMC) Source : ORCID

  42. Addition of taxanes to combination chemotherapy in distal intestinal gastric cancer is more beneficial than proximal ones: A multicenter retrospective study of Turkish Oncology Group

    Journal of B.U.ON., 2019

    Source : ORCID

  43. The hematologic parameters in metastatic castration-resistant prostate cancer patients treated with abiraterone acetate

    Journal of Clinical Oncology, 2019

    DOI 10.1200/jco.2019.37.7_suppl.308 2 citations (OpenAlex) Source : ORCID

  44. The outcome of loco-regional radiotherapy in metastatic castration-resistant prostate cancer patients treated with abiraterone acetate

    Journal of Clinical Oncology, 2019

    DOI 10.1200/jco.2019.37.7_suppl.316 1 citation (OpenAlex) Source : ORCID

  45. Pertuzumab, trastuzumab and taxane-based treatment for visceral organ metastatic, trastuzumab-naïve breast cancer: real-life practice outcomes

    Cancer Chemotherapy and Pharmacology, 2018

    DOI 10.1007/s00280-018-3712-7 PMID 30377778 8 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  46. Pertuzumab, trastuzumab and taxane combination for visceral organ metastatic patients: Real life practice results

    Annals of Oncology, 2018

    DOI 10.1093/annonc/mdy272.315 1 citation (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  47. Prognostic value of basal neutrophil lymphocyte ratio in patients with extensive stage small cell lung cancer

    Çukurova medical journal (Online)/Çukurova medical journal, 2018

    DOI 10.17826/cumj.458042 1 citation (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  48. Does cyclin E and p57kıp2 expression have prognostic and survival value in colorectal adenocarcinoma?

    International journal of clinical and experimental pathology, 2018

    PMID 31949774 Texte intégral en libre accèsSource : ORCID

  49. Genetic polymorphisms in human telomerase reverse transcriptase (hTERT) gene polymorphisms do not associated with breast cancer in patients in a turkish population: hospital-based case-control study.

    Cellular and molecular biology (Noisy-le-Grand, France), 2018

    DOI 10.14715/cmb/2018.64.1.3 PMID 29506639 5 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

  50. Clinicohistopathological features and treatment outcomes in testicular lymphomas: A single center experience

    Journal of Clinical Oncology, 2018

    DOI 10.1200/jco.2018.36.15_suppl.e16533 Source : ORCID